AIM:Interferon α2b (IFNα2b) and thymosin α1 (Tα1) exhibit synergic effects in the treatment of hepatitis B and hepatitis C when used together. For developing a fusion protein drug, fusion proteins of IFNα2b and T...AIM:Interferon α2b (IFNα2b) and thymosin α1 (Tα1) exhibit synergic effects in the treatment of hepatitis B and hepatitis C when used together. For developing a fusion protein drug, fusion proteins of IFNα2b and Ta1 linked by different lengths of (G4S)n(n = 1-3) were constructed and expressed in Pichia pastoris. METHODS: Using PCR and molecular clone techniques, the fusion genes of IFNα2b-(G4S)n-Tα1 (n = 1-3) were constructed and subcloned into the eukaryotic expression vector pPIC9. After transformation of these plasmids into P. pastoris, the expressed fusion proteins IFNα2b-(G4S) n-Tα1 (n = 1-3) were obtained. These proteins were purified through diethylaminoethyl (DEAE) affinity chromatography and Superdex?75 gel filtration and analyzed by SDS-PAGE and Western blot. Antiviral and E-rosette assays were used to investigate the bioactivities of these fusion proteins. RESULTS: DNA sequencing confirmed that the fusion genes of IFNa2b-(G4S)n-Tα1 (n= 1-3) were correctly cloned to the pPIC9 vector. The recombinant IFNα2b-(G4S)n-Tα1 (n = 1-3) fusion proteins expressed in P. pastoris were purified with DEAE and Superdex?75 gel filtration chromatography. The fusion proteins could be observed on sodium dodecylsulfate-polyacrylamide gel electrophoresis with molecular weight (MW) of 23.2, 22.9, and 22.6 ku, respectively, and reacted to the IFNa2b monoclonal antibody and Tal polyclonal antibody. The purified fusion proteins exhibit antiviral activity and can enhance the percentage of E-rosette-forming-cell in E-rosette assay. CONCLUSION: The recombinant IFNa2b-(G4S)n-Tα1 (n = 1-3) fusion proteins were successfully expressed in P. pastoris. Purified fusion proteins exhibit both antiviral activity of IFNa2b and immunomodulatory activity of Tal in vitro. These results will be the basis for further evaluation of the fusion proteins' function in vivo.展开更多
Objective To express human B7. 2 extracellular domain with prokaryote expression system and to evaluate its biological activity in vitro. Methods PCR was used to amplify the extracellular region of human B7. 2 which c...Objective To express human B7. 2 extracellular domain with prokaryote expression system and to evaluate its biological activity in vitro. Methods PCR was used to amplify the extracellular region of human B7. 2 which contained both the IgV and IgC domains. The recombinant PGEX-4T-3/hB7. 2 (IgV+C) was obtained by cloning the PCR product into a prokaryote expression plasmid PGEX-4T-3 and was transformed into the host strain of DH5-a. Tke fusion protein consisted of GST and hB7. 2(IgV+C) was identified by SDS-PAGE and Western blotting. T cell activation was observed by exposing purified T lymphocytes to the fusion protein and [3H]-TdR incorporation with the presence of the first signal imitated hy anti-CD3 antibody. Results The fusion protein GST-hB7. 2 (IgV+ C) was produced and detected in inclusive body form from engineered bacterial cells. With the first signal existed,T lymphocytes proliferated when it was co-stimulated by the fusion protein. Conclusion These results indicated that the functional human B7. 2(IgV+C) fusion protein can be produced in bacterial cells and the fusion protein displays the co-stimulatory activity in T lymphocytes activation.展开更多
Objective: To explore the mechanisms of microRNA-150, cyclin B1 and mitochondrial-associated protein 2 in regulating the apoptosis and inhibiting the invasion and migration of Huh-7 cells. Methods: Huh-7 cells were di...Objective: To explore the mechanisms of microRNA-150, cyclin B1 and mitochondrial-associated protein 2 in regulating the apoptosis and inhibiting the invasion and migration of Huh-7 cells. Methods: Huh-7 cells were divided into the control group, the negative control group (NC group) and the miR-150 overexpression group (mimic group). The miR-150 overexpressing cell line was constructed by plasmid transfection. The cell viability and apoptosis were detected by cell counting kit-8 and flow cytometry. The cell migration and invasion capacity were measured by cell wound scratch assay and Transwell. The levels of miRNA and mRNA were detected by real-time quantitative polymerase chain reaction and the relative expression levels of proteins were detected by Western blot. Results: MiR-150 significantly inhibited the cell viability of Huh-7 and promoted its apoptosis (P<0.01). After 24 h of cultivation, the mobility of the control group and the NC group were (83.54±4.66)%and (85.57±4.74)%, respectively. The mobility of the mimic group was (49.63±3.78)%, which was significantly lower than that of the control group and the NC group (P<0.01). After 24 h of cultivation, the invasive rate of the control group and the NC group were (100.56±2.87)%and (101.63±3.74)%, respectively, and the invasive rate of mimic group was (51.63±5.32)%, which was significantly lower than that of the control group and the NC group (P<0.01). The expression levels of cyclin B1 protein and mRNA in the mimic group were significantly lower than those in the control group and the NC group (P<0.01), and the level of mitochondrial-associated protein 2 in the mimic group was significantly higher than that in the control group and the NC group (P<0.01). Conclusions: MiR-150 may inhibit the proliferation, migration, invasion and apoptosis of hepatoma carcinoma cell by regulating cyclin B1 or up-regulating mitochondrial-associated protein 2 levels.展开更多
The human α-interferon(IFNα) is a group of proteins possessing activity to render cells resistant to viral infection. It is one of the most promising and well documented recombinant proteins used in biotherapy. A pr...The human α-interferon(IFNα) is a group of proteins possessing activity to render cells resistant to viral infection. It is one of the most promising and well documented recombinant proteins used in biotherapy. A product of recombinant human α2a-interferon(IFN-α2a) first developed in our laboratory has been put into clinical trials upon the approval of the China National Committee for Drug Administration. Data show that展开更多
The DNA fragments coding for preS2(120 146) and preS1(21 47) amplified by PCR were fused to both 5′ and 3′ ends of S gene at the position of amino acid 223. The fusion gene was placed downstream of the promoter P7.5...The DNA fragments coding for preS2(120 146) and preS1(21 47) amplified by PCR were fused to both 5′ and 3′ ends of S gene at the position of amino acid 223. The fusion gene was placed downstream of the promoter P7.5 of the universal vaccinia viral vector pGJP 5 and the recombinant vaccinia virus vS2SS1 was then selected by \%in vivo\% homogeneous recombination. Fusion protein S2SS1 could be expressed in the mammalian cells infected with vS2SS1. The investigation of expression, secretion, antigenicity and particle assembly of the S2SS1 protein demonstrated that S2SS1 protein could be assembled into particles which presented preS1, preS2 and S antigenicity and be efficiently secreted from the cells. It also showed that the level of its expression and secretion approached to that of the S protein expressed by the recombinant vaccinia virus.展开更多
文摘AIM:Interferon α2b (IFNα2b) and thymosin α1 (Tα1) exhibit synergic effects in the treatment of hepatitis B and hepatitis C when used together. For developing a fusion protein drug, fusion proteins of IFNα2b and Ta1 linked by different lengths of (G4S)n(n = 1-3) were constructed and expressed in Pichia pastoris. METHODS: Using PCR and molecular clone techniques, the fusion genes of IFNα2b-(G4S)n-Tα1 (n = 1-3) were constructed and subcloned into the eukaryotic expression vector pPIC9. After transformation of these plasmids into P. pastoris, the expressed fusion proteins IFNα2b-(G4S) n-Tα1 (n = 1-3) were obtained. These proteins were purified through diethylaminoethyl (DEAE) affinity chromatography and Superdex?75 gel filtration and analyzed by SDS-PAGE and Western blot. Antiviral and E-rosette assays were used to investigate the bioactivities of these fusion proteins. RESULTS: DNA sequencing confirmed that the fusion genes of IFNa2b-(G4S)n-Tα1 (n= 1-3) were correctly cloned to the pPIC9 vector. The recombinant IFNα2b-(G4S)n-Tα1 (n = 1-3) fusion proteins expressed in P. pastoris were purified with DEAE and Superdex?75 gel filtration chromatography. The fusion proteins could be observed on sodium dodecylsulfate-polyacrylamide gel electrophoresis with molecular weight (MW) of 23.2, 22.9, and 22.6 ku, respectively, and reacted to the IFNa2b monoclonal antibody and Tal polyclonal antibody. The purified fusion proteins exhibit antiviral activity and can enhance the percentage of E-rosette-forming-cell in E-rosette assay. CONCLUSION: The recombinant IFNa2b-(G4S)n-Tα1 (n = 1-3) fusion proteins were successfully expressed in P. pastoris. Purified fusion proteins exhibit both antiviral activity of IFNa2b and immunomodulatory activity of Tal in vitro. These results will be the basis for further evaluation of the fusion proteins' function in vivo.
基金This work was supported by the National Natural Science Foundation of China(No. 39470293).
文摘Objective To express human B7. 2 extracellular domain with prokaryote expression system and to evaluate its biological activity in vitro. Methods PCR was used to amplify the extracellular region of human B7. 2 which contained both the IgV and IgC domains. The recombinant PGEX-4T-3/hB7. 2 (IgV+C) was obtained by cloning the PCR product into a prokaryote expression plasmid PGEX-4T-3 and was transformed into the host strain of DH5-a. Tke fusion protein consisted of GST and hB7. 2(IgV+C) was identified by SDS-PAGE and Western blotting. T cell activation was observed by exposing purified T lymphocytes to the fusion protein and [3H]-TdR incorporation with the presence of the first signal imitated hy anti-CD3 antibody. Results The fusion protein GST-hB7. 2 (IgV+ C) was produced and detected in inclusive body form from engineered bacterial cells. With the first signal existed,T lymphocytes proliferated when it was co-stimulated by the fusion protein. Conclusion These results indicated that the functional human B7. 2(IgV+C) fusion protein can be produced in bacterial cells and the fusion protein displays the co-stimulatory activity in T lymphocytes activation.
文摘Objective: To explore the mechanisms of microRNA-150, cyclin B1 and mitochondrial-associated protein 2 in regulating the apoptosis and inhibiting the invasion and migration of Huh-7 cells. Methods: Huh-7 cells were divided into the control group, the negative control group (NC group) and the miR-150 overexpression group (mimic group). The miR-150 overexpressing cell line was constructed by plasmid transfection. The cell viability and apoptosis were detected by cell counting kit-8 and flow cytometry. The cell migration and invasion capacity were measured by cell wound scratch assay and Transwell. The levels of miRNA and mRNA were detected by real-time quantitative polymerase chain reaction and the relative expression levels of proteins were detected by Western blot. Results: MiR-150 significantly inhibited the cell viability of Huh-7 and promoted its apoptosis (P<0.01). After 24 h of cultivation, the mobility of the control group and the NC group were (83.54±4.66)%and (85.57±4.74)%, respectively. The mobility of the mimic group was (49.63±3.78)%, which was significantly lower than that of the control group and the NC group (P<0.01). After 24 h of cultivation, the invasive rate of the control group and the NC group were (100.56±2.87)%and (101.63±3.74)%, respectively, and the invasive rate of mimic group was (51.63±5.32)%, which was significantly lower than that of the control group and the NC group (P<0.01). The expression levels of cyclin B1 protein and mRNA in the mimic group were significantly lower than those in the control group and the NC group (P<0.01), and the level of mitochondrial-associated protein 2 in the mimic group was significantly higher than that in the control group and the NC group (P<0.01). Conclusions: MiR-150 may inhibit the proliferation, migration, invasion and apoptosis of hepatoma carcinoma cell by regulating cyclin B1 or up-regulating mitochondrial-associated protein 2 levels.
基金Project supported by grants from the State Commission of ScienceTechnology for the "863" Project for the Research and Development of Biotechnology.
文摘The human α-interferon(IFNα) is a group of proteins possessing activity to render cells resistant to viral infection. It is one of the most promising and well documented recombinant proteins used in biotherapy. A product of recombinant human α2a-interferon(IFN-α2a) first developed in our laboratory has been put into clinical trials upon the approval of the China National Committee for Drug Administration. Data show that
文摘The DNA fragments coding for preS2(120 146) and preS1(21 47) amplified by PCR were fused to both 5′ and 3′ ends of S gene at the position of amino acid 223. The fusion gene was placed downstream of the promoter P7.5 of the universal vaccinia viral vector pGJP 5 and the recombinant vaccinia virus vS2SS1 was then selected by \%in vivo\% homogeneous recombination. Fusion protein S2SS1 could be expressed in the mammalian cells infected with vS2SS1. The investigation of expression, secretion, antigenicity and particle assembly of the S2SS1 protein demonstrated that S2SS1 protein could be assembled into particles which presented preS1, preS2 and S antigenicity and be efficiently secreted from the cells. It also showed that the level of its expression and secretion approached to that of the S protein expressed by the recombinant vaccinia virus.
